Sulfadiazine crystalluria in a patient with lupus nephritis
It is estimated that 29% of patients treated with sulfadiazine ultimately develop acute kidney failure. Diagnosis is based on urine sediment analysis.
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2022-06-01
|
| Series: | Advances in Laboratory Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/almed-2022-0046 |
| _version_ | 1827916305302290432 |
|---|---|
| author | Ruiz Álvarez Maria Jesús Molina Blas Sergio Barrionuevo González Marta Peñas Lorite M. Eugenia Gasalla Herraiz José Manuel |
| author_facet | Ruiz Álvarez Maria Jesús Molina Blas Sergio Barrionuevo González Marta Peñas Lorite M. Eugenia Gasalla Herraiz José Manuel |
| author_sort | Ruiz Álvarez Maria Jesús |
| collection | DOAJ |
| description | It is estimated that 29% of patients treated with sulfadiazine ultimately develop acute kidney failure. Diagnosis is based on urine sediment analysis. |
| first_indexed | 2024-03-13T03:12:05Z |
| format | Article |
| id | doaj.art-ac0c198701ef45c58f8a39d3f3a04244 |
| institution | Directory Open Access Journal |
| issn | 2628-491X |
| language | English |
| last_indexed | 2024-03-13T03:12:05Z |
| publishDate | 2022-06-01 |
| publisher | De Gruyter |
| record_format | Article |
| series | Advances in Laboratory Medicine |
| spelling | doaj.art-ac0c198701ef45c58f8a39d3f3a042442023-06-26T10:46:04ZengDe GruyterAdvances in Laboratory Medicine2628-491X2022-06-013221021110.1515/almed-2022-0046Sulfadiazine crystalluria in a patient with lupus nephritisRuiz Álvarez Maria Jesús0Molina Blas Sergio1Barrionuevo González Marta2Peñas Lorite M. Eugenia3Gasalla Herraiz José Manuel4Service of Clinical Biochemistry, Hospital Universitario Príncipe de Asturias, Madrid, SpainService of Clinical Biochemistry, Hospital Universitario Príncipe de Asturias, Madrid, SpainService of Clinical Biochemistry, Hospital Universitario Príncipe de Asturias, Madrid, SpainService of Clinical Biochemistry, Hospital Universitario Príncipe de Asturias, Madrid, SpainService of Clinical Biochemistry, Hospital Universitario Príncipe de Asturias, Madrid, SpainIt is estimated that 29% of patients treated with sulfadiazine ultimately develop acute kidney failure. Diagnosis is based on urine sediment analysis.https://doi.org/10.1515/almed-2022-0046crystallurialupusmalta crossnephrotic syndromesulfadiazine |
| spellingShingle | Ruiz Álvarez Maria Jesús Molina Blas Sergio Barrionuevo González Marta Peñas Lorite M. Eugenia Gasalla Herraiz José Manuel Sulfadiazine crystalluria in a patient with lupus nephritis Advances in Laboratory Medicine crystalluria lupus malta cross nephrotic syndrome sulfadiazine |
| title | Sulfadiazine crystalluria in a patient with lupus nephritis |
| title_full | Sulfadiazine crystalluria in a patient with lupus nephritis |
| title_fullStr | Sulfadiazine crystalluria in a patient with lupus nephritis |
| title_full_unstemmed | Sulfadiazine crystalluria in a patient with lupus nephritis |
| title_short | Sulfadiazine crystalluria in a patient with lupus nephritis |
| title_sort | sulfadiazine crystalluria in a patient with lupus nephritis |
| topic | crystalluria lupus malta cross nephrotic syndrome sulfadiazine |
| url | https://doi.org/10.1515/almed-2022-0046 |
| work_keys_str_mv | AT ruizalvarezmariajesus sulfadiazinecrystalluriainapatientwithlupusnephritis AT molinablassergio sulfadiazinecrystalluriainapatientwithlupusnephritis AT barrionuevogonzalezmarta sulfadiazinecrystalluriainapatientwithlupusnephritis AT penasloritemeugenia sulfadiazinecrystalluriainapatientwithlupusnephritis AT gasallaherraizjosemanuel sulfadiazinecrystalluriainapatientwithlupusnephritis |